Zhou CK, Check DP, Lortet-Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer 2016; 138: 1388-400.
Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of followup. Lancet 2014; 384: 2027–2035.
 Beauval JB, Ploussard G, Soulié M, et al. Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study. Urology. 2012 Sep; 80(3):656-60.
Jansen FH, van Schaik RH, Kurstjens J, et al.Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection. Eur Urol. 2010; 57: 921-7.
 Guazzoni G, Nava L, Lazzeri M, et al. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. Eur Urol. 2011; 60: 214-22.
 Lazzeri M, Haese A, Abrate A, et al. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.BJU Int. 2013; 112(3):313-21.
 Guazzoni G, Lazzeri M, Nava L, et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.Eur Urol. 2012 Mar;61(3):455-66. doi: 10.1016/j.eururo.2011.10.038. Epub 2011 Nov 4.
 Fossati N, Buffi NM, Haese A, et al.Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.Eur Urol. 2015 Jul;68(1):132-8. doi: 10.1016/j.eururo.2014.07.034. Epub 2014 Aug 16.
 Maxeiner A, Kilic E, Matalon J, et al.The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients. Oncotarget. 2017 Apr 27;8(45):79279-79288. doi: 10.18632/oncotarget.17476. eCollection 2017 Oct 3.
 Epstein JI, Allsbrook WC Jr., Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29:1228-42
 Van der Kwast TH, Amin MB, Billis A, et al. International Socienty of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Speciments. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011;24:16-25
 Semjonow A, Köpke T, Eltze E, et al. Pre-analytical in-vitro stability of [-2] pro PSA in blood and serum. Clin Biochem 2010;43:496-8
 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-45.
 Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in2008:GLOBOCAN2008. Int J Cancer2010;127:2893–917.
 Miyake H, Fujisawa M. Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches.Int J Urol. 2013 Mar;20(3):301-11.
 Dolejsova O, Kucera R, Fuchsova R, et al. The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy.Technol CancerResTreat.2018;17:1533033818787377
 Hashimoto T, Yoshioka K, Horiguchi Y, et al. Clinical effect of a positive surgical margin without extraprostatic extension after robot-assisted radical prostatectomy.Urol Oncol. 2015 Dec; 33(12):503.e1-6.
 Sooriakumaran P, Haendler L, Nyberg T, et al. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.Eur Urol. 2012 Nov; 62(5):768-74.